 |
Masato Tanaka |
1. Asano K, Takahashi N, Ushiki M, Monya M, Aihara F, Kuboki E, Moriyama S, Iida M, Kitamura H, Qiu CH, Watanabe T, Tanaka M.
Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes.
Nat Commun. 6: 7802. 2015
2. Karasawa K, Asano K, Moriyama S, Ushiki M, Monya M, Iida M, Kuboki E, Yagita H, Uchida K, Nitta K, Tanaka M.
Vascular-Resident CD169-Positive Monocytes and Macrophages Control Neutrophil Accumulation in the Kidney with Ischemia-Reperfusion Injury.
J. Am. Soc. Nephrol. 26: 896-906. 2015
3. Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, Kanagawa O, Fujii S, Tanaka M.
CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens.
Immunity 34: 85-95. 2011
4. Nabeyama A, Kurita A, Asano K, Miyake Y, Yasuda T, Miura I, Nishitai G, Arakawa S, Shimizu S, Wakana S, Yoshida H, Tanaka M.
xCT deficiency accelerates chemically induced tumorigenesis.
Proc. Natl. Acad. Sci. USA. 107: 6436-41. 2010
5. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M.
Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens.
J. Clin. Invest. 117: 2268-78. 2007